Pages that link to "Q37609816"

The following pages link to Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure (Q37609816):

Displaying 47 items.

• From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia (Q24605527) (← links)
• Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects? (Q26852683) (← links)
• How animal models of leukaemias have already benefited patients (Q26997702) (← links)
• Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome (Q27012691) (← links)
• Endoplasmic reticulum calcium pumps and cancer cell differentiation (Q33649613) (← links)
• HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells (Q33689028) (← links)
• The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. (Q34024558) (← links)
• All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129. (Q34240112) (← links)
• Aberrant corepressor interactions implicated in PML-RAR(alpha) and PLZF-RAR(alpha) leukemogenesis reflect an altered recruitment and release of specific NCoR and SMRT splice variants. (Q34575940) (← links)
• Combination of arsenic and interferon-α inhibits expression of KSHV latent transcripts and synergistically improves survival of mice with primary effusion lymphomas (Q35046691) (← links)
• Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview). (Q35155855) (← links)
• Reactive oxygen species regulate the differentiation of acute promyelocytic leukemia cells through HMGB1-mediated autophagy (Q35402749) (← links)
• Targeting expression of the leukemogenic PML-RARα fusion protein by lentiviral vector-mediated small interfering RNA results in leukemic cell differentiation and apoptosis (Q35612561) (← links)
• Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells (Q35677279) (← links)
• Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling (Q35879576) (← links)
• On-Demand Targeting: Investigating Biology with Proximity-Directed Chemistry (Q36723089) (← links)
• Effect of GINS2 on proliferation and apoptosis in leukemic cell line (Q37334072) (← links)
• Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia. (Q37396013) (← links)
• Deficiency of SUMO-specific protease 1 induces arsenic trioxide-mediated apoptosis by regulating XBP1 activity in human acute promyelocytic leukemia (Q37407152) (← links)
• Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. (Q37640483) (← links)
• PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity. (Q37686992) (← links)
• RXRα ligand Z-10 induces PML-RARα cleavage and APL cell apoptosis through disrupting PML-RARα/RXRα complex in a cAMP-independent manner (Q37707093) (← links)
• Targeting leukemic stem cells by breaking their dormancy (Q37769764) (← links)
• Towards novel paradigms for cancer therapy. (Q37799251) (← links)
• Acute promyelocytic leukaemia: novel insights into the mechanisms of cure (Q37802188) (← links)
• The molecular physiology of nuclear retinoic acid receptors. From health to disease (Q37802557) (← links)
• Retinoids, Retinoic Acid Receptors, and Cancer (Q37809078) (← links)
• Differentiation syndrome in patients with acute promyelocytic leukemia (Q37848580) (← links)
• Arsenic in the treatment of newly diagnosed acute promyelocytic leukemia: current status and future research direction (Q37890950) (← links)
• What is the standard regimen for patients with acute promyelocytic leukemia? (Q38204310) (← links)
• RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells (Q38758034) (← links)
• Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression. (Q39028638) (← links)
• Inhibitor mediated protein degradation. (Q42178606) (← links)
• Sp100 as a Potent Tumor Suppressor: Accelerated Senescence and Rapid Malignant Transformation of Human Fibroblasts through Modulation of an Embryonic Stem Cell Program (Q42699664) (← links)
• The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability (Q42713949) (← links)
• The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia (Q42781521) (← links)
• Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting (Q43068233) (← links)
• Antioxidants Protect against Arsenic Induced Mitochondrial Cardio-Toxicity (Q47249055) (← links)
• Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha (Q47806060) (← links)
• Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy (Q48525923) (← links)
• Identification of the STAT5B-RARα fusion transcript in an acute promyelocytic leukemia patient without FLT3, NPM1, c-Kit and C/EBPα mutation. (Q54600383) (← links)
• Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations. (Q55515402) (← links)
• RXR, un cofacteur essentiel à la transformation dans les leucémies aiguës promyélocytaires (Q57778786) (← links)
• Awakening dormant haematopoietic stem cells (Q58379701) (← links)
• All-Trans Retinoic Acid Enhances Matrix Metalloproteinase 2 Expression and Secretion in Human Myeloid Leukemia THP-1 Cells (Q58702062) (← links)
• Mechanisms of leucemogenesis (Q82313937) (← links)
• Genomics and electronic health record systems (Q88613788) (← links)